Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0R33.L
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 5.33 1.18 1.12
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -56.14 -4.90 11.17
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 0.99 36.58 36.22
Cash 11.54 4.06 3.64
Capex -6.38 -0.14 -0.13
Free Cash Flow 95.36 1.16 0.59
Revenue 6.18 7.66 7.21
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -51.44 -0.23 0.47
Operating Margin 1528.61 -0.52 0.03
ROA 253.37 0.01 < 0.005
ROE 249.00 0.02 < 0.005
ROIC 1320.91 -0.06 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0R33.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0R33.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0R33.L is permitted for members.